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Abstract
Visualizing the physical basis for molecular behavior inside living cells is a grand challenge in 
biology. RNAs are central to biological regulation, and RNA’s ability to adopt specific structures 
intimately controls every step of the gene expression program1. However, our understanding of 
physiological RNA structures is limited; current in vivo RNA structure profiles view only two of 
four nucleotides that make up RNA2,3. Here we present a novel biochemical approach, In Vivo 
Click SHAPE (icSHAPE), that enables the first global view of RNA secondary structures of all 
four bases in living cells. icSHAPE of mouse embryonic stem cell transcriptome versus purified 
RNA folded in vitro shows that the structural dynamics of RNA in the cellular environment 
distinguishes different classes of RNAs and regulatory elements. Structural signatures at 
translational start sites and ribosome pause sites are conserved from in vitro, suggesting that these 
RNA elements are programmed by sequence. In contrast, focal structural rearrangements in vivo 
reveal precise interfaces of RNA with RNA binding proteins or RNA modification sites that are 
consistent with atomic-resolution structural data. Such dynamic structural footprints enable 
accurate prediction of RNA-protein interactions and N6-methyladenosine (m6A) modification 
genome-wide. These results open the door for structural genomics of RNA in living cells and 
reveal key physiological structures controlling gene expression.
Selective 2’-Hydroxyl Acylation followed by Primer Extension (SHAPE) accurately 
identifies flexible (single stranded) bases in RNA for all four bases. However, current 
methods are potentially limited by high background (>70% of RNA molecules have no 
modification due to single hit kinetics) and high false positive rates due to spurious reverse 
transcription (RT) stops4. We overcome these problems by developing a new SHAPE probe 
that permits in vivo SHAPE modification and subsequent selective purification of the 
modified RNAs.
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We designed, synthesized, and tested a novel bifunctional chemical probe for in vivo RNA 
structure profiling genome-wide (NAI-N3, Fig. 1a, 1b, and Extended Data Fig 1). NAI-N3 
adds an azide group to NAI, a cell permeable SHAPE reagent5. By using copper-free click 
chemistry, a biotin moiety is selectively and efficiently added to NAI-N3-modified RNA, 
providing a stringent purification handle with streptavidin beads (Fig. 1c, Extended Data 
Fig. 2). NAI-N3 generated identical profiles of RT stops to those obtained using our 
previously designed SHAPE reagent5. The fidelity of structural measurements was not 
affected by “clicking” biotin onto the NAI-N3 nor by molecular crowding of proteins, and 
NAI-N3 showed uniform modification of all bases in denatured RNAs (Extended Data Fig. 
3). We term this new chemoaffinity structure probing methodology In Vivo Click SHAPE 
(icSHAPE); this method can also be applied to any ex vivo preparation of RNA with slight 
modifications.
icSHAPE of ribosomal RNAs in mouse embryonic stem cells (mESC) indicated that it is 
quantitative and accurate, reporting the known structures of 18S and 28S rRNAs (Fig. 1d-f 
and Extended Data Fig. 4). Manual structure-probing gels and deep sequencing results 
from icSHAPE revealed high correlations (Pearson correlation r=0.93, in vivo; Fig. 1d and 
Extended Data Fig. 4). Ribosomal RNA is known to require the cellular environment for 
proper folding, and differences between in vivo and in vitro icSHAPE measurements 
highlighted important structural elements in the intact ribosome. We mapped nucleotides of 
icSHAPE difference to the cryo-EM structure of the human 80S ribosome6 and searched for 
differences between the in vivo and in vitro conditions. Conserved (mouse to human) 
nucleotides of high icSHAPE signal in vivo were unpaired in the cryo-EM structure (Fig. 
1e); conversely residues lacking icSHAPE reactivity in vivo were base-paired or engaged in 
extensive interactions that may stabilize the RNA backbone in the mature ribosome (Fig. 
1f). Overall, these data demonstrate that icSHAPE accurately measures RNA structures, 
both in and outside of living cells.
We next used icSHAPE to measure RNA structural profiles of polyadenylated transcripts in 
mESCs and generated ~2.1 billion measurements for over 13,200 RNAs in vivo and in vitro, 
with high reproducibility (Extended Data Fig. 5 and 6). The nucleotide composition in the 
transcriptome, mock-treated RNA, and icSHAPE RNA are highly concordant, with a slight 
enrichment in NAI-N3 samples for A’s and U’s (Fig. 2a). This enrichment is expected given 
their bias for being located in single stranded or loop regions7. icSHAPE thus affords the 
first complete RNA structurome of all four nucleotides in vivo.
icSHAPE data revealed the scale and distribution of RNA structural dynamics between in 
vitro, where folding is programmed entirely by sequence, versus in vivo where folding 
occurs in the context of the intracellular environment.8 Recent transcriptome-wide 
dimethylsulfate probing (DMS-seq), which interrogates two bases with strong bias toward 
adenosines (68% A’s and 24% C’s)2,4, suggests that RNA structures are largely unfolded in 
vivo2; however sampling only two of four nucleotides could result in an incomplete picture. 
We quantified RNA structural dynamics using two metrics: First, we calculated the 
difference in reactivity between our in vivo and in vitro icSHAPE measurements, termed the 
Vivo – Vitro Difference (VTD, Fig. 2b and Methods). Adenosine residues have the largest 
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VTD, whereas guanosine and cytidine residues are less variable between environments (Fig. 
2c). These observations suggest that utilizing probes that have a broader reactivity profile 
such as NAI-N3 will give a more complete representation of RNA structure.
Second, we used the GINI index2 to quantify the distribution of icSHAPE reactivity profiles. 
Structured RNAs have some bases that are reactive and some not, leading to unequal 
distribution and high GINI, while unfolded RNAs have most bases in a uniformly reactive 
conformation (low GINI). We found that RNAs are less folded in vivo, consistent with a 
prior report2, but the extent of unfolding varies in degrees that distinguish different classes 
of RNAs (Fig. 2d). Protein-coding mRNAs exhibited noticeable but partial unfolding 
(average GINI of 0.7 in vitro to 0.5 in vivo), with the largest variation noted at 3’ 
untranslated regions (UTR) compared to coding sequences (CDS) or 5’UTRs. In contrast, 
noncoding RNAs, such as pseudogenes, long noncoding RNAs, and primary microRNA 
precursors, retain substantially more of their RNA structure in vivo (p< 2.2×10−16, 
noncoding vs. coding, Student’s t-test). One exception to this rule are snoRNAs, which 
exhibit the greatest level of increased reactivity in vivo among all classes of transcripts and 
may result from extensive rearrangements due to snoRNP binding. Most RNAs in vivo 
possess a substantial level of RNA structure beyond previous expectation based on DMS-
seq2. The current data suggest that RNA structural signatures in vivo can distinguish coding 
vs. structural or regulatory RNAs, consistent with prior in vitro studies9-12.
The dramatically different environments that RNA experiences when inside a cell compared 
to in vitro predicts that our VTD parameter could provide insight into functionally important 
RNA regulatory elements. To assess this possibility, we measured the VTD for all hexamer 
sequences (Fig. 2e, Supplementary Table 1). We observed unique VTD profiles for 
sequence motifs driving diverse post-transcriptional processes, including translation 
initiation, interaction with RNA binding proteins (RBPs, e.g. Rbfox2), RNA modification 
(m6A), and microRNA seed matches13,14,15 (Supplementary Table 1 and 2). These results 
show that the VTD may classify RNA regulatory elements as pre-programmed or sensitive 
to in vivo remodeling. Further, distinctive VTD profiles precisely at sites of post-
transcriptional regulatory motifs suggest that RNA structural dynamics may be used to 
monitor these regulatory events in cells.
We hypothesized that translational regulatory elements may have their icSHAPE profiles 
conserved between in vivo and in vitro because the Kozak sequence, important for 
translation initiation16, is among the most stable (low VTD) regions within mRNAs (Fig. 
2d). RNA accessibility from −1 to −5 nucleotides upstream of the start codon plays a major 
role in regulating translational output10,17. We used translation initiation18 and pause sites18, 
defined by ribosome profiling, to center our structural reactivity analysis across the 
transcriptome (Fig. 3). Canonical initiation AUG sites are indeed preceded by ~5 nts of 
increased accessibility, and this pattern is nearly identical to in vitro folded RNA (Fig. 3a 
and 3b). A similar pattern of conserved upstream accessibility also precedes noncanonical 
start sites at upstream open reading frames (uORF) and N-terminal truncations (Fig. 3c). 
Non-start site AUG codons are also associated with increased preceding reactivity, while 
noncanonical CUG start codons have a different profile, suggesting that RNA accessibility 
alone is not sufficient to dictate translational start sites (Extended Data Fig. 7). Ribosome 
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profiling also defined ribosome pause sites as having a strong preference for glutamate or 
aspartate in the A-site, where transfer RNA (tRNA) identity and the nascent peptide 
sequence are believed to strongly influence translation kinetics18. icSHAPE data at ribosome 
pause sites revealed a distinctive signature: loss of reactivity at the E and P sites while the A 
site is more reactive, preceded by strong 3-nt periodic reactivity pattern 5’ to the pause site 
for ~12 nts (Fig. 3d and 3e). Furthermore, a very similar pattern was observed in vitro under 
conditions that do not maintain mRNA interactions with the ribosome or tRNAs, suggesting 
that these structural profiles are programmed by mRNA sequence. Analysis of negative 
control sites – defined as sites on the same transcripts that match the codon composition, are 
in frame, and are at least 20 nts away from true pause sites – showed a very similar 
icSHAPE signature at the presumed ribosome E, P, and A sites, but negative controls lacked 
the 5’ periodic signal (gray box in Fig. 3e and 3f). This observation suggests that the 
icSHAPE signature at ribosome pause sites is likely due to the codon bias at such sites, but 
sequences 5’ to the pause may influence pausing. These results identify several 
physiological structural signatures of translational control elements, and suggest they may 
be largely pre-programmed by mRNA sequence.
In contrast, focal RNA structural rearrangements in vivo can identify sites of RBP 
interactions, which regulate RNA splicing, localization, and stability19 (Fig. 2d). The 
forkhead box (Fox) family of RBPs important for tissue-specific control of alternative 
splicing, with Rbfox2 playing key roles in ES cells.14,20 High VTD at the known Rbfox2 
binding motif (UGCAUG)14,20 indicates a strong structural rearrangement in vivo. 
Alignment with Rbfox:RNA NMR structure21 and Rbfox2 binding sites identified by 
individual-nucleotide crosslinking immunoprecipitation (iCLIP) in mESC20 showed that 
differential icSHAPE signal precisely matches the key RNA residues involved in Rbfox 
interaction (Fig. 4a and 4b). U1, G2, and A4 in the motif showed strong icSHAPE VTD 
signal. The 2’ hydroxyl groups of these three residues are flipped outward while G2 and A4 
base pair upon Rbfox interaction21, consistent with adoption of new structural environments 
in vivo that we detect at these residues. In principle, dynamic structural footprints of RBPs 
may enable comprehensive readout of RNA-RBP interactions in vivo. We tested this idea by 
implementing a Support Vector Machine (SVM) algorithm to learn dynamic icSHAPE 
signals that are best able to predict sites of RNA regulation, using held out data for cross-
validation of prediction accuracy (Extended Data Fig. 8 and Methods). Indeed, the 
combination of both in vivo and in vitro icSHAPE data increased the ability to predict true 
Rbfox2 binding sites compared to motif sequence or conservation alone, particularly at 
lower false positive rates where accuracy is most important (Area Under the Curve [AUC] = 
0.74, Extended Data Fig. 8).
As an independent validation, we used icSHAPE data to predict the binding sites of HuR, a 
RBP that regulates transcript stability15, and also performed the first HuR iCLIP in mESCs. 
Comparing in vivo vs. in vitro icSHAPE data precisely identified peaks of structural 
arrangement at authentic HuR binding sites (defined by iCLIP sites), and enabled reasonably 
accurate prediction of HuR binding from icSHAPE data alone (AUC = 0.841, Extended 
Data Fig. 8, HuR iCLIP data in Extended Data Fig. 9). Thus, icSHAPE data can 
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distinguish true binding sites from other sequence motif instances, collectively boosting 
prediction accuracy.
We also identified a critical connection between RNA structure and RNA modification, a 
newly appreciated and pervasive mode of post-transcriptional control13. The most prevalent 
modification in mRNAs, m6A, occurs at GGm6ACU motifs near stop codons, and acts in 
part to control RNA splicing and stability22,23. It has been hypothesized that m6A 
methylation occurs at sites that contain un-paired motifs24, but no direct structural evidence 
has been presented to support this model. Comparison of icSHAPE signals at m6A-modified 
vs. unmodified instances of the GGACU motif in mESCs25 revealed a specific structural 
signature, with stronger icSHAPE reactivity (consistent with unpaired RNA) at positions 
both surrounding and including the modified A (Fig. 4d, Extended Data Fig. 8). m6A sites 
in different subdomains of mRNAs or in lncRNAs have nearly identical icSHAPE profiles 
(Extended Data Fig. 10). Evaluation of all predictive features using our SVM algorithm 
showed that motif conservation or motif position offers some predictive value (AUC=0.617 
or 0.824, respectively) as previously reported24, but use of icSHAPE data (AUC = 0.846) or 
all features together (AUC = 0.914) improved prediction rate (Fig. 4e). These results show 
that icSHAPE structure profiles can be used to accurately predict post-transcriptional 
modifications on a transcriptome-wide scale.
The strong RNA structural signature at m6A sites may arise from the ability m6A to 
destabilize RNA helices26 (represented in Fig. 4c) or the structural selectivity of m6A 
modification machinery for unpaired bases. In the former scenario, removal of m6A should 
cause increased basepairing (loss of icSHAPE signal) whereas the latter scenario predicts 
little change to RNA structural profile. To distinguish between these hypotheses, we 
determined the icSHAPE profile of mESCs genetically ablated for Mettl325, a key m6A 
methyltransferase that is required for ESC differentiation. We observed that in Mettl3 
knockout cells, canonical motif sites that lost m6A modification also substantially lost 
icSHAPE signal transcriptome-wide (Fig. 4d), as exemplified by key m6A target sites in 
Nanog mRNA (Fig. 4f). These results suggest that m6A impacts RNA structure, favoring the 
transition from paired to unpaired RNA. The ability to couple genetic perturbation with 
comprehensive, base-resolution structural maps in vivo is a potentially powerful approach to 
dissect regulators of RNA structure.
Understanding how RNA structures contribute to biological regulation opens the door to 
understanding a physical dimension of the transcriptome. icSHAPE bridges a gap in RNA 
sequencing technologies that currently lack the ability to infer a mechanistic basis of 
biological function. The ability to view the structural dynamics of all four RNA bases in 
living cells is essential to uncover specific sequence motifs underlying different modes of 
post-transcriptional regulation27, and has enabled accurate identification and de novo 
prediction of trans-acting factor binding and chemical modification at single nucleotide 
resolution. In the future, viewing the RNA structurome when cells are exposed to different 
stimuli or genetic perturbations should revolutionize our understanding of gene regulation in 
biology and medicine.
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Methods
Methyl 2-(azidomethyl)nicotinate
1.00 g of methyl 2-methylnicotinate was dissolved in 5 mL anhydrous dichloromethane. 
2.30 g trichloroisocyanuric acid was added and the resulting suspension stirred overnight at 
room temperature. The reaction was diluted with dichloromethane and quenched by the 
addition of saturated sodium bicarbonate solution. The phases were separated and the 
organic phase was washed once with brine, dried over magnesium sulfate, filtered, and 
concentrated to afford a yellow oil. NMR data was consistent with literature reports.
The crude product of the above reaction (1.09 g) was dissolved in 12 mL anhydrous N,N-
dimethylformamide and 0.77 g sodium azide was added. The reaction was stirred overnight 
at room temperature then quenched with saturated sodium bicarbonate solution. The 
aqueous layer was extracted with ethyl acetate, and the organic layer washed 3 times with 
water and 3 times with brine. The organic layer was dried over magnesium sulfate, filtered, 
and concentrated to afford 0.91 g (71%, 2 steps) of a yellow oil that solidified upon 
standing.
1H NMR (400 MHz, CDCl3): 3.94 (3H, s), 4.88 (2H, S), 7.37 (1H, m), 8.29 (1H, dd, J = 8 
Hz, 1.6 Hz), 8.76 (1H, dd, J = 4.6 Hz, 1.6 Hz)
13C NMR (100 MHz, CDCl3): 52.8, 54.4, 122.9, 125.0, 139.1, 152.4, 156.7, 166.0
ESI-MS (Calc M-H = 191.06): 191.98
2-(azidomethyl)nicotinic acid
0.50 gram of methyl 2-(azidomethyl)nicotinate was stirred vigorously in 10 mL of 1:1 
MeOH:10% aqueous NaOH. After 10 minutes TLC indicated complete consumption of 
starting material. 25 mL of water were added, the crude reaction mixture was washed once 
with ether (10 mL) then acidified to pH 4 with 10% aqueous HCl and extracted 5 times with 
50 mL ethyl acetate. The organic layer was dried over magnesium sulfate, filtered, and 
concentrated to afford 0.46 g (99%) of a white solid that was pure by NMR.
1H NMR (400 MHz, DMSO-d6): 4.81 (2H, s), 7.50 (1H, m), 8.28 (1H, dd, J = 7.8 Hz, 1.6 
Hz), 8.74 (1H, dd, J = 5 Hz, 1.6 Hz), 13.64 (1H, br. s).
13C NMR (100 MHz, DMSO-d6): 53.4, 123.4, 125.9, 139.0, 151.9, 156.0, 167.1
ESI-MS (Calc M-H = 177.04): 177.05
2-(azidomethyl)nicotinic acid acyl imidazole
0.15 g 2-(azidomethyl)nicotinic acid was dissolved in 0.21 mL anhydrous 
dimethylsulfoxide. A solution of 0.14 g carbonyldiimidazole in 0.21 mL anhydrous 
dimethylsulfoxide was added dropwise, creating rapid gas evolution. The reaction was 
allowed to proceed for one hour and the resulting solution used as a 2M stock solution for 
RNA SHAPE experiments. For NMR data collection an analytical sample was prepared in 
dichloromethane as described above. The reaction was stirred over night and the solvent 
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removed in vacuum. The product was then isolated by flash column chromatography on 
silica (ethyl acetate).
1H NMR (400 MHz, DMSO-d6): 4.62 (2H, s), 7.16 (1H, dd, J = 1.7 Hz, 0.8 Hz), 7.60 (1H, 
dd, J = 7.9 Hz, 4.9 Hz), 7.66 (1H, m), 8.15 (2H, m), 8.84 (1H, dd, J = 4.9 Hz, 1.7 Hz).
13C NMR (100 MHz, DMSO-d6): 52.8, 117.9, 123.0, 127.3, 130.9, 137.7, 138.5, 151.9, 
154.6, 164.7
In Vitro transcription and acylation of RNA
RNA was transcribed from amplified inserts using T7 Megascript kit from Ambion, 
following manufacturer’s protocol. In a typical in vitro modification protocol, RNA was 
heated in metal-free water for two minutes at 95°C. The RNA was then flash-cooled on ice. 
The RNA 3x SHAPE buffer (333 mM HEPES, pH 8.0, 20mM MgCl2, 333mM NaCl) was 
added and the RNA was allowed to equilibrate at 37°C for ten minutes. To this mixture, 1μL 
of 10x electrophile stock in DMSO (+) or DMSO (−) was added. The reaction was permitted 
to continue until the desired time. Reactions were cleaned up using RNeasy columns 
(Qiagen) following manufactures protocol and eluted RNase-free water.
In Vitro manual SHAPE analysis
32P-end-labeled DNA primer (reverse primer above) was annealed to 3μg of total RNA by 
incubating at 95°C for two minutes followed by a step-down cooling (2°/sec) to 4°C. To the 
reaction first-strand buffer, DTT and dNTPs were added. The reaction was pre-incubated at 
52 °C for one minute, then Superscript III (2U/μLfinal concentration) was added. Extensions 
were performed for ten minutes. To the reaction, 1μL of 4M NaOH was added and allowed 
to react for 5 minutes at 95°C. 10μL of Gel Loading Buffer II (GLBII, Ambion, Inc.) was 
then added, and cDNA extensions were resolved on 8% denaturing (7M Urea) 
polyacrylamide gels (29:1 acrylamide:bisacrylamide, 1xTBE). All (−) lanes are those from 
DMSO control treated cells. In addition, all sequencing lanes are from DMSO control 
treated cells. cDNA extensions were visualized by phosphorimaging (STORM, Molecular 
Dynamics). cDNA bands were integrated with SAFA28 SHAPE reactivities were normalized 
to a scale spanning 0 to 1.5, where 1.0 is defined as the mean intensity of highly reactive 
nucleotides.29 RNA secondary structures were predicted using mFOLD software.30
Characterization of manual SHAPE-enriched RT stops
Copper-free click chemistry of acylated RNA—In a typical reaction, acylated RNA 
(1pmol) was reacted with 100eq. of DIBO-biotin (Life Technologies) for two hours, at 
37°C, in 1x Phosphate Buffer Saline (PBS). Reactions were extracted once with acid 
phenol:chloroform (pH 4.5±0.2) and twice with chloroform. RNA was precipitated with 
40μL of 3M sodium acetate buffer (pH 5.2) and 1μL of glycogen (20μg/μL). Pellets were 
washed twice with 70% ethanol and resuspended in 10μL RNase-free water.
Enrichment of NAI-N3 modified RNA—The following protocol was used for manual 
enrichment protocols used to optimize capture conditions. To 1pmol of precipitated and 
biotinylated RNA (in 900μL of binding buffer: 50mM Tris-HCl pH 7.0 and 1mM EDTA) 
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was added 50μL (slurry) of DYNAL MyOneC1 beads (Life Technologies) was added. The 
reaction mixture was then incubated for one hour at room temperature. The beads were then 
collected on a magnetic plate and the solution decanted. The beads were then resuspended 
and washed 4 times with Biotin Wash Buffer (10mM Tris-HCl, pH 7.0, 1mM EDTA, 4M 
NaCl, 0.2% Tween). The beads were then washed 3x with RNase-free water. To elute the 
purified RNA off the resin beads were incubated in 1X proteinase K buffer with 20U of 
proteinase K (Life Technologies), 1mM D-Biotin (Sigma Aldrich), and 20U of SUPERaseIn 
(Life Technologies). The reaction was permitted to run for 30 minutes at 37°C.Beads were 
then collected by magnet and the supernatant removed and set on ice. This was repeated 
twice more and elutions were pooled. Reactions were extracted once with acid 
phenol:chloroform (pH 4.5±0.2) and twice with chloroform. RNA was precipitated with 
40μL of 3M sodium acetate buffer (pH 5.2) and 1μL of glycogen (20 μg/μL). Pellets were 
washed twice with 70% ethanol and resuspended in 10μL RNase-free water.
Dot Blot analysis of enriched NAI-N3 modified RNA—Hybond N+ membranes (GE) 
were pre-incubated in 1xPBS. Precipitated RNA was dissolved in 100μL of 1xPBS. RNA 
was added to the Hybond membrane and crosslinked using 254nm UV light. The Hybond 
membrane was washed three times with 1xPBS. To the membrane was added 
NorthernLights Streptavidin NL493 (in PBS-Tween20) for visualization. After incubation, 
the membrane was washed 3x in 1xPBS-Tween20. The membrane was dried and imaged by 
phosphorimaging (STORM, Molecular Dynamics).
Tissue culture and In Vivo SHAPE modification
Mouse embryonic stem cells (v6.5 line) were grown on gelatinized dishes in serum and LIF. 
Unmodified total RNA was extracted by removing media, washing once in room 
temperature 1xPBX, and adding 2mL (10cm dish) or 7mL (15cm dish) of Trizol directly to 
the cells. Subsequent RNA extract was performed using the miRNeasy mini- or midi-
column and protocol (Qiagen) as recommended by the manufacture. In Vivo modification of 
cellular RNAs was performed as described previously.5 Briefly, cells were rinsed once on 
the plate in room temperature 1xPBS, decanted, scraped in 1xPBS, and collected into a 
15mL tube. Cells were pelleted at room temperature and resuspended in 450μL of 1xPBS. 
50μL of 10x electrophile stock in DMSO (+) or DMSO (−) was added drop-wise, 
immediately mixed by inversion, and incubated at 37°C on end-over-end rotation for 20 
minutes. Reactions were pelleted for 1min at 4°C at 10,000 rpm and resuspended in 500μL 
of 1xPBS. Samples were then transferred to 15mL tubes with 2-7mL of pre-aliquoted Trizol 
and RNA extracted as described above.
Methods to ensure titrated hit-kinetics of RNA modification—We titrated NAI-N3 
for single-hit kinetics that are comparable to those routinely used in chemical probing of 
RNA structure. For example, we obtained nearly identical secondary structure for 5S rRNA 
as previously reported with single hit regime.5 After NAI-N3 modification and biotin 
pulldown, we retrieved approximately 10-20% of the input RNA as modified RNA, 
consistent with the expected Poisson distribution of single-hit modification.
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icSHAPE deep sequencing library preparation
RNA preparation—DMSO (mock) or NAI-N3 (experimental) modified total RNA was 
used as input for the deep sequencing library preparation. Before library preparation input 
RNA should be modified (or mock treated) under In Vitro or In Vivo conditions as described 
above. For “total RNA” libraries, no additional processing was needed. For “poly-A 
selected” samples, 200μg of total RNA was used per poly-A purist column (Ambion, Inc.), 
which should yield ~2μg of enriched RNA. Poly-A selection was performed a total of two 
times using the same poly-dT beads (“double poly-A selection). The NAI-N3 sample may 
have lower yield post purification so additional starting material could be required.
NAI-N3 biotinylation and RNA fragmentation—All RNA samples (NAI-N3 and 
DMSO treated) are processed through a copper-free “click” reaction. RNA is brought to 
97μL in 1xPBS and 1μL of SUPERaseIn and 2μL of 185mM DIBO-Biotin are added. 
Samples were mixed by brief vortexing and then incubated at 37°C for 2 hours in a 
Thermomixer (Eppendorf). Reactions were stopped by adding 350μL of Buffer RLT 
(Qiagen) and then 900μL of 100% ethanol (EtOH). Each RNA sample was processed by 
passing over a RNeasy Mini column (Qiagen), two 500μL washes with Buffer RPE 
(Qiagen), one no-buffer spin to dry the column, and finally two 50μL elutions in RNase-free 
water (final 100μL). Samples were then frozen for 5 minutes on dry ice and concentrated to 
9μL using a lyophilizer (Labconco). Concentrated RNA samples (9μL) were then moved to 
0.5mL PCR tubes for fragmentation. Samples were heated to 95°C for 90 seconds and then 
1μL of 10x RNA Fragmentation Reagent (Ambion, Inc.) was added and samples were 
placed back at 95°C for 70-90 seconds. Reactions were quenched by adding 1μL of RNA 
Fragmentation Stop Solution (Ambion, Inc.) and moved to ice. RNA was cleaned up by 
adding 35μL of Buffer RLT and 100μL of 100% EtOH and purified using RNeasy Mini 
columns as above. Samples are then concentrated with a lyophilizer to 5μL.
RNA end repair, RNA ligation, and RNA size selection—To resolve the 3’-end 
phosphate generated by the fragmentation process T4 PNK is used. To each 5μL sample 2μL 
of 5x PNK buffer (350mM Tris-HCl pH 6.5, 50mM MgCl2, 25mM DTT), 1μL 
SUPERaseIn, and 2μL of T4 PNK (NEB) is added, mixed by flicking, and incubated at 37°C 
for 1 hour. After end-repair samples are moved directly to 3’-end ligation by adding 1μL of 
50μM 3’ Adaptor, 1μL of 10x T4 RNL2tr buffer (NEB), 1.5μL of T4 RNL2tr K227Q 
(NEB), 1μL of 100mM DTT, and 8μL of 50% PEG8000. Mix samples by flicking and 
incubate at 16°C overnight.
Ligation Note: NAI-N3 samples must use “3’-Adaptor-3’ddc” (/5rApp/AGATCGGA 
AGAGCGGTTCAG/3ddC/) while DMSO samples must use “3’-Adaptor-3’Biotin” (/5rApp/
AGATCGGAAGAGCGGTTCAG/3Bio/). The “click” chemistry will label only the NAI-N3 
modified RNAs in the NAI-N3 pool of transcripts with a biotin moiety, thus allowing the 
selective purification of structurally informative molecules. The DMSO samples are not 
capable of “click” chemistry and every molecule in this pool is desired for sequencing so 
addition of a biotin moiety must happen in an unbiased fashion. Thus, DMSO samples have 
a 3’Biotin modification added specifically to their 3’ Adaptor to allow for downstream 
processing in parallel of the DMSO and NAI-N3 samples.
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After the overnight ligation 30μL of water, 185μL of Buffer RLT, and 400μL of 100% EtOH 
is added to each sample and purified using RNeasy Mini columns as above. Samples are 
concentrated to 5μL using a lyophilizer and 5μL of GLBII is added and stored on ice. To 
size select the RNA samples a mini 6% TBE PAGE gel with 7M Urea is cast and pre-run to 
50W for 8 minutes. Samples are loaded without prior heating and the PAGE gel is imaged 
using a 1:10,000 dilution of SybrGold (Life Technologies). RNA is visualized on a BlueBox 
(Clare Chemical) and fragmented RNA ranging between 20-120nts (40-140nts with the 3’ 
Adaptor ligated) are excised with a scalpel. Gel slices are crushed through a 0.75mL tube 
nested in a 2mL tube by centrifugation and 300μL of Crush Soak Buffer (500mM NaCl, 
1mM EDTA) is added with 3μL of SUPERaseIn. RNA is eluted overnight at 4°C on 
rotation.
RT, streptavidin capture, cDNA elution, and cDNA size selection—RNA samples 
are purified away from residual PAGE using 0.45μm Spin-X columns (Corning) and the 
300μL elutions are transferred to silicionized 1.5mL tubes (Fisher Scientific, used in all 
subsequent steps). RNA is precipitated by adding 30μL of 3M sodium acetate buffer (pH 
5.2), 0.8μL of GlycoBlue (Ambion, Inc.) and 1mL of 100% EtOH. Samples are frozen for 1 
hour on dry ice, spun at max speed (15,000 rpm) for 1 hour at 4°C, washed with 800μL of 
ice-cold 80% EtOH, decanted, air-dried and then resuspended in a 0.5mL PCR tube with 
11.5μL of water. To the RNA samples add 1μL of 10μM RT primer (/5phos/
DDDNNAACCNNNN AGATCGGAAGAGCGTCGTGAT/iSp18/GGATCC/iSp18 /
TACTGAACCGC, /5phos/ = 5’ phosphate, D=A/T/G, /iSp18/ = 18carbon PEG spacer) and 
1μL of 10mM dNTPs. Heat the samples to 70°C for 5 minutes and then cool slowly to 25°C 
(2deg/second) and hold at 25°C for one minute. After primer annealing add 0.5μL of 
SUPERaseIn, 1μL 100mM DTT, 4μL of 5x First Strand Buffer and 1μL of SuperScript III 
(Life Technologies). cDNA extension occurs for 3 minutes at 25°C, 7 minutes at 42°C, and 
finally at 52°C for 15 minutes. After cDNA extension do not raise samples above 37°C to 
avoid denaturing conditions.
MyOneC1 streptavidin beads for cDNA capture and NAI-N3 modified RNA enrichment are 
prepared (40μL slurry per sample) by washing 3x in 1mL of Biotin Bind Buffer (100mM 
Tris-HCl pH 7.0, 10mM EDTA, 1M NaCl) and resuspending the beads in 40μL Biotin Bind 
Buffer and 1μL SUPERaseIn per reaction. After the reverse transcription reaction completes 
40μL of pre-washed beads are added to each sample, mixed by flicking, and incubated at 
room temperature for 45 minutes. After streptavidin capture samples are washed at room 
temperature serially with 4×100μL of Biotin Wash Buffer, 2×100μL 1xPBS and finally 
moved to 1.5mL tubes. cDNA is eluted by adding 1μL RNaseA/T1 cocktail (Ambion, Inc) 
1μL RNaseH (Enzymatics), 12.5μL 50mM D-Biotin, 5μL 10x Elution Buffer (500mM 
HEPES, 750mM NaCl, 30mM MgCl2, 1.25% Sarkosyl, 0.25% Na-deoxycholate, 50mM 
DTT), 30.5μL water and incubating at 37°C for 30min in a Thermomixer at 800 rpm. 
Samples are mixed with 1μL 100% DMSO, heated to 95°C for 3 minutes, placed on a 
magnet, and the 50μL cDNA elution moved to a new tube. The elution is repeated once 
(total of two times and final of 100μL). cDNA is processed by adding 1mL of Buffer PNI 
and purifying over a MiniElute columns (Qiagen) following manufactures protocol and 
eluting twice in 15μL of Buffer EB (final 30μL). cDNAs are concentrated using a lyophilizer 
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to 5μL and equal volume of GLBII is added. Size selection of cDNAs is performed as was 
done for the RNA size selection. 6% PAGE gel pre-running is critical to achieve denaturing 
conditions as well as heating the samples to 95°C for 3 minutes prior to PAGE separation. 
cDNAs are selected for insert sizes of ~20-120nts (~85-205nts with RT primer extension) 
and depending on the input material amount the libraries may be invisible at this step. Gel 
slices are crushed as above, 300μL of Crush Soak Buffer is added and cDNAs are eluted at 
50°C overnight on rotation.
cDNA circularization, library qPCR, library size selection, sequencing PCR—
Purification of eluted cDNA is performed as above for RNA elution. After cDNA 
precipitation samples are resuspended in 16μL of water, 2μL of 10x CircLigaseII Buffer, 
1μL of CircLigaseII (Epicentre) and moved to 0.5mL PCR tubes. cDNA circularization 
takes place at 60°C for 120 minutes in a PCR machine. Circularized cDNA is purified by 
adding 200μL of Buffer PNI and processing as above using MiniElute columns, eluting the 
cDNA twice in 14μL (final ~27μL). Samples are initially amplified in a 60μL qPCR reaction 
(27μL cDNA, 30μL 2x Phusion HF Master Mix, 0.75μL of 10μM P3_short primer 
(CTGAACCGCTCTTCCGATCT), 0.75μL of 10μM P5_short primer 
(ACACGACGCTCTTCCGATCT), 0.72μL of 25x SybrGold). The qPCR machine is 
programmed as follows: 98°C for 1 minute, 98°C for 15 seconds, 62°C for 30 seconds, 72°C 
for 45 seconds). After qPCR amplification samples are purified with 600μL of Buffer PNI 
and MiniElute columns as above. Library DNA is eluted twice in 15μL (total 30μL) and 
concentrated using a lyophilizer to less than 5μL. A second 6% TBE 7M Urea PAGE gel 
selection is performed as above to remove any PCR dimer products and all short qPCR 
primers. Gel slices are crushed as above and eluted overnight at 50°C on rotation. 
Purification of library DNA is performed as above post PAGE gel elution and after 
precipitation resuspended in 19μL of water. A final library PCR amplification is performed 
for three cycles in 40μL reactions (19μL library DNA, 0.5μL of 10μM P3_solexa primer 
(CAAGCAGAAGACGGCA TACGAGATCGGTCTCGG 
CATTCCTGCTGAACCGCTCTTCCGATCT), 0.5μL of 10μM P5_solexa primer 
(AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACA 
CGACGCTCTTCCGATCT)) and cleaned up using Agencourt AMPure XP beads 
(Beckman) according to manufactures protocol and eluted the library in 20μL of water. Final 
library material was quantified on the BioAnalyzer High Sensitivity DNA chip (Agilent) and 
then sent for deep sequencing on the Illumina HiSeq2500 machine for 1×100bp cycle run.
iCLIP and data analysis
The iCLIP method was performed as described before with the specific modifications 
below36. v6.5 mESCs were grown as described above and UV-C crosslinked to a total of 
0.3J/cm2. Whole cell lysates were generated in CLIP lysis buffer (50mM HEPES, 200mM 
NaCl, 1mM EDTA, 10% Glycerol, 0.1% NP-40, 0.2% TritonX-100, 0.5% N-
lauroylsarcosine) and briefly sonicated using a probe-tip Branson sonicator to solubilize 
chromatin. Each iCLIP experiment was normalized for total protein amount, typically 2mg, 
and partially digested with RNaseA (Affymetrix) for 10 minutes at 37°C and quenched on 
ice. Immunoprecipitations of HuR were carried out with Protien G Dynabeads (Life 
Technologies) and anti-HuR antibody (3A2, Santa Cruz) for 3 hours at 4°C on rotation. 
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Samples were wash sequentially in 1mL for 5min each at 4°C: 2x high stringency buffer 
(15mM Tris-HCl pH7.5, 5mM EDTA, 2.5mM EGTA, 1% TritonX-100, 1% Na-
deoxycholate, 120mM NaCl, 25mM KCl), 1x high salt buffer (15mM Tris-HCl pH7.5, 5mM 
EDTA, 2.5mM EGTA, 1% TritonX-100, 1% Na-deoxycholate, 1M NaCl), 1x NT2 buffer 
(50mM Tris-HCl pH7.5, 150mM NaCl, 1mM MgCl2, 0.05% NP-40). 3’-end RNA 
dephosphorylation, 3’-end ssRNA ligation, 5’ labeling, SDS-PAGE separation and transfer, 
autoradiograph, RNP isolation, ProteinaseK treatment, and overnight RNA precipitation 
took place as previously described36. The 3’-ssRNA ligation adaptor was modified to 
contain a 3’biotin moiety as a blocking agent. The iCLIP library preparation was performed 
as described previously36. Final library material was quantified on the BioAnalyzer High 
Sensitivity DNA chip (Agilent) and then sent for deep sequencing on the Illumina 
HiSeq2500 machine for 1×75bp cycle run. iCLIP data analysis was performed as previously 
described.36
RNA Structure Analysis
Sequencing, reads mapping, and data quality control—We generated four 
replicates for each library (DMSO PolyA, NAI PolyAin vivo and in vitro). We performed 
single-end sequencing on Illumina’s HiSeq sequencer and obtained approximately 200-
million to 600-million raw reads for each replicates, totaling 3.9-billion reads. We collapsed 
these reads to remove PCR duplicates (only reads that have identical sequences including 
barcode region are regarded as duplicates). Collapsed reads were then subjected to barcode 
removal and primer and linker trimming by using Trimmomatic31. We mapped trimmed 
reads to the mouse transcriptome of the Ensembl annotation (build GRCm38.7432) by using 
Bowtie233.For reads that can be mapped to multiple locations of the transcriptome, we 
evenly distribute them to up to ten random hits. Finally, we obtained 2.1 billion mapped 
reads in total. We define the −1 positions of the 5-prime the mapped reads as RT stops, 
which correspond to modified positions in the NAI libraries, and intrinsic modified (or 
fragmentation) positions in the DMSO libraries. We defined RT stop coverage as the 
number of times a base is mapped as a RT stop.
We calculated the expression level of all transcripts in the mouse transcriptome in terms of 
RPKM. The correlations of transcript expression value (RPKM>0.1) in different replicates 
are very high (in the range of 0.96 to 1.00). We constructed the background base density 
profile for each transcript as the sequencing depth of each base in the DMSO libraries. We 
also calculated the correlation of RT stops for each transcript in different replicates. As 
shown in Extended Data Figure 5, the correlation is high for most transcripts if we limit to 
transcripts of average RT stop coverage higher than 2 and regions of background base 
density higher than 200. So for each library (DMSO poly-A, NAI poly-A in vivo and in 
vitro) we combine all four replicates into one for the following analysis.
Reactivity score calculation and construction of structural profile—We 
performed a 5%-5% normalization for each transcript (i.e., The mean of the RT stops of the 
second top 5% bases, excluding the 32 bases at the beginning and 32 bases in the end of the 
transcript, will be normalized to 1. All RT stops will be normalized proportionally).
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We defined reactivity score as the subtraction of background RT stops (DMSO libraries) 
from RT stops of the modified NAI libraries, and then adjusted by the background base 
density:
R = (RT_stopNAI – αRT_stopDMSO) / background_base_densityDMSO
The score is then scaled into the range of [0, 1], after removing the outliers by 90% 
Winsorization (the top 5th percentile is set to 1 and the bottom 5th percentile is set to 0. We 
trained the parameter α on the ribosomal RNA structures, and set it to 0.25 to maximize the 
correlation of reactively score R determined by deep sequencing and reactivity score 
measured in low throughput gel shift experiments.
For each transcript, we defined its structural profile as the vector of base-resolution 
reactivity scores from the beginning to the end. The valid structural profile of a transcript is 
limited to regions of RT stop coverage higher than 2 and background base density higher 
than 200. Finally, we obtained valid structural profiles for, respectively, 19,347 and 13,281 
transcripts from in vivo and in vitro, polyA-selected RNA libraries, among which the 
majority are messenger RNAs (Extended Data Figure 6).
Metagene analysis of translation sites, pause site, m6A sites and protein 
binding sites—We calculated metagene structure profile around different functional sits 
by averaging all valid reactivity score R: (1), 10 nts upstream and downstream of the RNA 
methylation m6A site, as determined in by our lab previously34; (2), 25 nts upstream and 
downstream of the translation pause site determined in the same ribosome profiling 
experiment; (3), 25 nts upstream and downstream of the RNA methylation m6A site, (4) 25 
nts upstream and downstream of the binding sites of RNA binding protein Rbfox235 and 
HuR (Extended Data Figure 8 and 9. See details below).
In the analysis of differential profiles of icSHAPE reactivity scores around m6A and 
negative control sites, we retrieved a set of target m6A sites that have icSHAPE reactivity 
scores in both wild type and Mettl3 knock out cells, and defined a set of similar number of 
non-methylated m6A site with the same sequence motifs (GGACU). For both wild type and 
knock out cells, we calculated the profiles of average reactivity scores in target sites and 
negative controls and subtracted the latter from the former scores to define the differential 
icSHAPE profiles.
We calculated in vivo and in vitro metagene structure profile separately. For each transcript 
functional sites and their flanking regions, we demand a stringent R score for thousands of 
transcripts being compared. We generated roughly the same number of negative controls for 
each set of functional sites. And whenever a sequence motif exists for a functional site, we 
use that motif in generating the negative control. For example, the same sequence motif 
GGACU is used to scan the transcriptome and negative controls are randomly selected from 
the hits excluding regions that are close to a true m6A site.
The HuR iCLIP experiments are performed and clusters of binding sites are determined with 
the pipeline as described previously.36 Threshold 9 (at least 9 unique RT stops are each 
genomic coordinate) is used to filter for the true binding sites. The highest peak and its 
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flanking 50 nucleotides in each cluster were retrieved and used to call sequence motifs by 
using HOMER38, with random sequences of 50 nucleotides from the same set of transcripts 
as background. The motifs are used as the anchor point in calculating metagene profiles and 
also used to generate negative controls, using the same protocol as the m6A negative control 
generation described above.
VTD (in vivo and in vitro structure difference) analysis—We defined and 
calculated the VTD profile of a transcript by subtracting its valid in vitro structural profile 
from the in vivo one. We calculate the average VTD profiles for all 4096 possible hexamers 
in our structurome. The overall VTD score of each hexamer is defined as the average score 
across the 6 bases of the hexamer.
We retrieved sequence motifs of important functional sites, including Kozak sequences 
(GCCRCC), m6A sites (GGACU), miR-290 family 6-mer seed matches (GCACUU, 
complementary to the seeds), and Rbfox2 binding sites (UGCAUG), and highlighted their 
VTD scores on the VTD histogram of all hexamers. For sites with ambiguity, for example, 
m6A sites, we took the average of all hexamers that contain GGACU.
We also compiled a resource (Supplementary Table 1 and 2) of VTD scores for all RNA 
protein binding motifs studied by RNAcompete experiments39, and all mouse microRNA 6-
mer seed matches from miRBase40. In addition to the VTD scores, for every motif or seed 
match, we asked three questions by using permutation test: 1), whether the absolute value of 
the motif (or seed match) VTD is significantly less than a random hexamer, i.e., represents a 
stable region; 2), whether the motif (or seed match) VTD is significantly smaller than a 
random hexamer, i.e., represents a region that is more structured in vivo; and 3), whether the 
motif (or seed match) VTD is significantly bigger than a random hexamer, i.e., represents a 
region that is more structured in vitro.
Structure-based prediction of m6A sites and protein binding sites—We 
constructed a set of SVM models41 for the prediction of m6A sites and protein binding sites 
using structural profiles, genomic locations, conservations and their combinations.
The structural profile is limited to the range from the −10 to the +10 position of the m6A site 
or the motifs of the protein binding sites. We used in vivo and in vitro reactivity score 
separately and jointly in making predictions. We also retrieved a set of genomic features for 
the prediction of m6A sites and protein binding sites, including whether the site is in the 
5’UTR, CDS, or 3’UTR, whether it is at the last exon, whether it is at the largest exon, the 
distance to start codon, the distance to stop codon, the distance to 5’ of the splicing junction, 
etc. In addition, we retrieved the UCSC 60-way phastCons conservation score42 for 
nucleotides in the range from the −10 to the +10 position of the m6A site or the motifs of the 
protein binding sites.
We used the same set of positive and negative controls and the best predictor is selected by 
using a parameter-searching tool coming along with the libsvm package (http://
www.csie.ntu.edu.tw/~cjlin/libsvm/). We used a five-fold cross validation and calculate the 
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AUC (area under curve) of the ROC (Receiver operating characteristic) curve to evaluate the 
performance of the predictors (Extended Data Figure 8).
Sequencing Datasets and Source Code
All genomic dataset are deposited on the Gene Expression Omnibus under the accession 
number GSE64169. Source code used for the icSHAPE analysis is deposited freely available 
at: https://github.com/qczhang/icSHAPE
Extended Data
Extended Data Figure 1. Chemical synthesis of NAI-N3
a, Synthetic scheme for NAI-N3. b, 1HMR of Methyl 2-(azidomethyl)nicotinate c, 1HNMR 
of 2-(azidomethyl)nicotinic acid d, 13CNMR of 2-(azidomethyl)nicotinic acid e, 1HNMR of 
2-(azidomethyl)nicotinic acid acyl imidazole f, 13CNMR of 2-(azidomethyl)nicotinic acid 
acyl imidazole.
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Extended Data Figure 2. NAI-N3 is a novel RNA acylation reagent that enables RNA 
purification
a, Chemical schematic of RNA acylation and copper-free ‘click’ chemistry utilizing NAI-N3 
and dibenzocyclooxtyne-biotin conjugate. b, ATP acylation gel shift showing ATP acylation 
and copper-free ‘click’ chemistry utilizing NAI-N3 and dibenzocyclooxtyne-biotin 
conjugate.
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Extended Data Figure 3. NAI-N3 is a novel RNA acylation reagent accurately reads out RNA 
structure
a, Comparative denaturing gel of NAI and NAI-N3 RNA acylation. b, Denaturing gel 
analysis of cDNAs that originate from the biotin-purification protocol (Extended Data 
Figure 1) c, Secondary structure of the SAM-I Riboswitch with enriched residues 
highlighted in orange and depleted residues highlighted in blue. d, Denaturing gel analysis 
of denatured RNA probed with NAI-N3 shows even coverage of 2’-hydroxyl reactivity 
when RNA is unfolded. e, Protein titration with BSA, demonstrating no difference in the 
SHAPE pattern as a function of protein concentration.
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Extended Data Figure 4. icSHAPE is capable of reproducing RNA acylation profiles obtained by 
manual RNA modification experiments
icSHAPE (right panels) profiles of ribosomal RNA and compared them to those obtained by 
manual SHAPE (left panels).
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Extended Data Figure 5. 
RT stops measured by icSHAPE is very well correlated in different library replicates
Extended Data Figure 6. icSHAPE is capable of measuring the RNA structure profiles of 
thousands of RNAs, simultaneously
a, The RNAs represented in polyA selected RNA, in vivo. b. The RNAs represented in 
polyA selected RNA, in vitro.
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Extended Data Figure 7. Non-AUG start codons are associated with preceding reactivity, and 
Non-AUG start codons have a different profile, suggesting that RNA accessibility alone is not a 
sufficient to drive translation
a, icSHAPE profile at AUG start codons, in vivo. b, icSHAPE profile at AUG start codons, 
in vitro. d, icSHAPE profile at CUG start codons, in vivo. d, icSHAPE profile at CUG start 
codons, in vitro
Extended Data Figure 8. icSHAPE can be used to predict posttranscriptional regulatory 
elements
a, icSHAPE profile at Rbfox2 targets, in vivo. b, icSHAPE profile at Rbfox2 targets, in 
vitro. c, ROC curve of Rbfox2 RNA-protein interactions, predicted using icSHAPE profiles. 
d, icSHAPE profile at m6A targets, in vivo. The negative control is the set of motif instances 
that are not m6A modified e, icSHAPE profile at m6A targets, in vitro. f, ROC curve of m6A 
RNA modification sites, predicted using icSHAPE profiles. g, icSHAPE profile at HuR 
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targets, in vivo. h, icSHAPE profile at HuR targets, in vitro. i, ROC curve of HuR RNA-
protein interactions, predicted using icSHAPE profiles.
Extended Data Figure 9. iCLIP analysis of HuR in mESCs
a, global binding preference of the RBP HuR in mESCs as represented by RT stops across 
the mouse transcriptome (mm9). HuR mainly binds protein coding, processed, and 
ribosomal RNAs. b, number of unique RNA transcripts bound by HuR. c, HuR RT stops 
distributed across protein coding transcript functional domains. HuR prefers intronic and 
3’UTR regions. d, Metagene analysis of all HuR bindings sites. Each mRNA region 
(5’UTR, CDS, or 3’UTR) was scaled to a standard unit width RT stop density across all 
bound protein coding genes was plotted revealing a clear enrichment for 3’UTR regions in 
mature protein coding transcripts. e, Individual mRNA binding evens of HuR to genes 
important for mESC biology including Tet1, β-Actin, Elav1 (HuR itself), and Lin28a. 
Discrete binding sites are observed focused in 3’UTR and intronic regions.
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Extended Data Figure 10. 
m6A-associated RNA structure features are preserved, independent of their position along 
the RNA transcript
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. icSHAPE is a Novel and Robust Method for Measuring RNA Structure
a, Chemical scheme for the preparation of acylated RNA, which can be purified by biotin-
streptavidin purification. b, Schematic of icSHAPE modification and purification steps to 
generate a sequencing library. c, Dot blot of biotin-modified RNA from icSHAPE through 
streptavidin affinity isolation. d, Denaturing gel electrophoresis of icSHAPE on rRNA from 
mESCs. The corresponding icSHAPE profile, generated from deep sequencing is to the 
right. e, Pymol representation of rRNA, corresponding to regions of icSHAPE that are more 
reactive in vivo (PDB3J3D). f, Pymol representation of rRNA, corresponding to regions of 
icSHAPE that are more reactive in vitro.
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Figure 2. icSHAPE Reveals Unique Structural Profiles for Nucleobase Reactivity and 
Posttranscriptional Interactions
a, RT stop distribution for the transcriptome, DMSO control, or icSHAPE libraries. b, 
icSHAPE data track and VTD calculation of the MALAT1 RNA (chr19:5796010-5796081). 
icSHAPE data are scaled from 0 (no reactivity) to 1 (max reactivity). c, The VTD 
distribution for icSHAPE libraries. d, GINI index of icSHAPE data in vivo vs. in vitro. e, 
The distribution of VTD profiles for all hexamer motifs across the transcriptome. Bin 
locations for several motifs for post-transcriptional regulation are highlighted.
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Figure 3. icSHAPE Reveals Structural Profiles Associated with Translation
a, Cartoon representation of ribosomes translating an mRNA. The uORF initiation site is 
represented by ribosome initiation upstream of the canonical start codon. The canonical start 
position is demarcated by “AUG”. The N-terminal truncation is represented as a ribosome 
initiating to the 3’-end of the canonical start “AUG”. b, icSHAPE profile at canonical start 
codon position. c, icSHAPE profiles at uORF and N-terminal truncation sites. d, Cartoon 
representation of a paused ribosome and its corresponding A-P-E sites. A: acceptor; P: 
peptidyl-transferase; E: exit. e, The icSHAPE profile at ribosome pause sites. f, icSHAPE 
profile at negative control sites for pause sequences. Gray box highlights a region of 
structural difference upstream of true pause sites vs. controls.
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Figure 4. icSHAPE Dynamics Reveals and Predicts Post-transcriptional Interactions
a, Structure of Rbfox1-RNA interaction, highlighting the RNA-protein interface. The RNA 
is shown with a blue backbone and orange bases; each 2’hydroxyl is green (PDB:2ERR). b, 
The differential icSHAPE profile at Rbfox2 target mRNAs measured in vivo vs. in vitro 
maps precisely to the Rbfox binding sites. c, Model of interplay between m6A and RNA 
structure. d, Differential icSHAPE signal for m6A methylated vs. non-methylated sites with 
the same underlying sequence motif, both in vivo. icSHAPE signal from unmodified sites 
are subtracted from m6A-modified sites; asterisks (*) indicate positions with significant 
differences (p<0.05, FDR<0.05). Data from wild type and Mettl3 KO mESCs are plotted for 
comparison. e, ROC curve for prediction of m6A sites, incorporating icSHAPE profiles. f, 
Effect of m6A on RNA structure on Nanog mRNA. Top: location of Mettl3-dependent m6A 
sites (highlight in yellow); m6A-RIP data from Batista et al25. Bottom: icSHAPE profile of 
WT and Mettl3 KO cells.
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Figure 5. 
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